PER percheron therapeutics limited

market depth, page-4

  1. SRF
    1,046 Posts.
    Because the reponse to the ASX query highlight the fact that the result is due and the tone seems positive.

    Like most of us think, it is rediculous for ANP to be at 1.6 cps at the stage of phase 1 human trial. (IMO, an equivelant of finding billions barrels of oil and testing if it is safe and recoverable) The next stage is live patient trial. (IMO it's like checking if the oil is commercial)

    All ANP needs is more publicity, SP should be at around 6 cps by now.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $1.76K 206.6K

Buyers (Bids)

No. Vol. Price($)
28 10989304 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 2286236 8
View Market Depth
Last trade - 15.14pm 16/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.